Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within E-cadherin signaling events 41.0 208.0 5.0 -0.098 0.017 1000.0 -1000.0 0.0 -1000.0 TCGA08_retinoblastoma 39.0 314.0 8.0 -0.081 0.054 1000.0 -1000.0 -0.004 -1000.0 Osteopontin-mediated events 33.0 1280.0 38.0 -0.173 0.021 1000.0 -1000.0 -0.003 -1000.0 Syndecan-1-mediated signaling events 32.0 1119.0 34.0 -0.127 0.017 1000.0 -1000.0 -0.007 -1000.0 LPA receptor mediated events 32.0 3299.0 102.0 -0.172 0.017 1000.0 -1000.0 -0.035 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 31.0 3901.0 125.0 -0.23 0.026 1000.0 -1000.0 -0.044 -1000.0 Endothelins 30.0 2940.0 96.0 -0.226 0.064 1000.0 -1000.0 -0.021 -1000.0 Integrins in angiogenesis 29.0 2502.0 84.0 -0.188 0.026 1000.0 -1000.0 -0.036 -1000.0 Ephrin B reverse signaling 28.0 1381.0 48.0 -0.108 0.074 1000.0 -1000.0 -0.011 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 27.0 921.0 34.0 -0.108 0.017 1000.0 -1000.0 -0.006 -1000.0 Thromboxane A2 receptor signaling 27.0 2878.0 105.0 -0.185 0.08 1000.0 -1000.0 -0.033 -1000.0 Wnt signaling 27.0 192.0 7.0 -0.076 0.015 1000.0 -1000.0 -0.008 -1000.0 Angiopoietin receptor Tie2-mediated signaling 27.0 2463.0 88.0 -0.278 0.046 1000.0 -1000.0 -0.051 -1000.0 Fc-epsilon receptor I signaling in mast cells 26.0 2534.0 97.0 -0.242 0.038 1000.0 -1000.0 -0.034 -1000.0 Nectin adhesion pathway 26.0 1700.0 63.0 -0.176 0.022 1000.0 -1000.0 -0.038 -1000.0 EPHB forward signaling 26.0 2283.0 85.0 -0.119 0.083 1000.0 -1000.0 -0.038 -1000.0 Syndecan-2-mediated signaling events 24.0 1709.0 69.0 -0.108 0.026 1000.0 -1000.0 -0.004 -1000.0 amb2 Integrin signaling 24.0 2012.0 82.0 -0.128 0.023 1000.0 -1000.0 -0.017 -1000.0 IL4-mediated signaling events 23.0 2169.0 91.0 -0.546 0.473 1000.0 -1000.0 -0.112 -1000.0 PDGFR-alpha signaling pathway 23.0 1021.0 44.0 -0.076 0.024 1000.0 -1000.0 -0.003 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 23.0 1751.0 74.0 -0.098 0.03 1000.0 -1000.0 -0.036 -1000.0 Noncanonical Wnt signaling pathway 22.0 572.0 26.0 -0.079 0.017 1000.0 -1000.0 -0.011 -1000.0 p75(NTR)-mediated signaling 22.0 2860.0 125.0 -0.139 0.051 1000.0 -1000.0 -0.038 -1000.0 BMP receptor signaling 22.0 1789.0 81.0 -0.105 0.035 1000.0 -1000.0 -0.044 -1000.0 E-cadherin signaling in keratinocytes 22.0 979.0 43.0 -0.097 0.021 1000.0 -1000.0 -0.009 -1000.0 E-cadherin signaling in the nascent adherens junction 21.0 1616.0 76.0 -0.103 0.026 1000.0 -1000.0 -0.035 -1000.0 Syndecan-4-mediated signaling events 21.0 1472.0 67.0 -0.16 0.026 1000.0 -1000.0 -0.016 -1000.0 S1P1 pathway 20.0 731.0 36.0 -0.107 0.017 1000.0 -1000.0 -0.03 -1000.0 Nongenotropic Androgen signaling 20.0 1070.0 52.0 -0.142 0.034 1000.0 -1000.0 -0.021 -1000.0 HIF-1-alpha transcription factor network 19.0 1458.0 76.0 -0.214 0.025 1000.0 -1000.0 -0.046 -1000.0 Syndecan-3-mediated signaling events 19.0 699.0 35.0 -0.1 0.051 1000.0 -1000.0 -0.017 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 19.0 1299.0 68.0 -0.325 0.144 1000.0 -1000.0 -0.045 -1000.0 S1P3 pathway 19.0 805.0 42.0 -0.103 0.026 1000.0 -1000.0 -0.01 -1000.0 LPA4-mediated signaling events 18.0 226.0 12.0 -0.05 0.006 1000.0 -1000.0 -0.001 -1000.0 IL23-mediated signaling events 18.0 1090.0 60.0 -0.42 0.017 1000.0 -1000.0 -0.044 -1000.0 IL12-mediated signaling events 17.0 1558.0 87.0 -0.257 0.047 1000.0 -1000.0 -0.085 -1000.0 Cellular roles of Anthrax toxin 17.0 693.0 39.0 -0.117 0.017 1000.0 -1000.0 -0.006 -1000.0 Arf6 signaling events 16.0 1011.0 62.0 -0.108 0.023 1000.0 -1000.0 -0.006 -1000.0 Signaling events mediated by PTP1B 16.0 1226.0 76.0 -0.118 0.03 1000.0 -1000.0 -0.023 -1000.0 Signaling events regulated by Ret tyrosine kinase 16.0 1386.0 82.0 -0.116 0.017 1000.0 -1000.0 -0.036 -1000.0 TCR signaling in naïve CD8+ T cells 16.0 1490.0 93.0 -0.073 0.026 1000.0 -1000.0 -0.03 -1000.0 Effects of Botulinum toxin 16.0 425.0 26.0 -0.118 0.017 1000.0 -1000.0 -0.005 -1000.0 IGF1 pathway 16.0 930.0 57.0 -0.127 0.035 1000.0 -1000.0 -0.037 -1000.0 Coregulation of Androgen receptor activity 15.0 1215.0 76.0 -0.153 0.035 1000.0 -1000.0 -0.013 -1000.0 IL1-mediated signaling events 15.0 933.0 62.0 -0.103 0.047 1000.0 -1000.0 -0.036 -1000.0 HIF-2-alpha transcription factor network 15.0 662.0 43.0 -0.219 0.11 1000.0 -1000.0 -0.047 -1000.0 Signaling mediated by p38-alpha and p38-beta 15.0 684.0 44.0 -0.096 0.017 1000.0 -1000.0 -0.012 -1000.0 EGFR-dependent Endothelin signaling events 15.0 323.0 21.0 -0.087 0.026 1000.0 -1000.0 -0.03 -1000.0 Plasma membrane estrogen receptor signaling 15.0 1352.0 86.0 -0.132 0.058 1000.0 -1000.0 -0.039 -1000.0 PDGFR-beta signaling pathway 15.0 1541.0 97.0 -0.115 0.021 1000.0 -1000.0 -0.036 -1000.0 Glypican 1 network 14.0 686.0 48.0 -0.12 0.028 1000.0 -1000.0 -0.009 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 14.0 1130.0 78.0 -0.103 0.032 1000.0 -1000.0 -0.023 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 13.0 1153.0 85.0 -0.127 0.017 1000.0 -1000.0 -0.032 -1000.0 Reelin signaling pathway 13.0 734.0 56.0 -0.112 0.047 1000.0 -1000.0 -0.031 -1000.0 Canonical Wnt signaling pathway 13.0 700.0 51.0 -0.128 0.032 1000.0 -1000.0 -0.017 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 13.0 1596.0 120.0 -0.16 0.05 1000.0 -1000.0 -0.036 -1000.0 Caspase cascade in apoptosis 12.0 951.0 74.0 -0.198 0.039 1000.0 -1000.0 -0.018 -1000.0 Signaling events mediated by the Hedgehog family 12.0 635.0 52.0 -0.063 0.026 1000.0 -1000.0 -0.015 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 12.0 460.0 37.0 -0.16 0.042 1000.0 -1000.0 -0.006 -1000.0 S1P5 pathway 12.0 219.0 17.0 -0.069 0.022 1000.0 -1000.0 -0.003 -1000.0 TCGA08_p53 12.0 90.0 7.0 -0.06 0.051 1000.0 -1000.0 -0.004 -1000.0 Glypican 2 network 12.0 51.0 4.0 -0.004 -0.001 1000.0 -1000.0 -0.0 -1000.0 Signaling events mediated by PRL 12.0 430.0 34.0 -0.049 0.026 1000.0 -1000.0 -0.008 -1000.0 Glucocorticoid receptor regulatory network 11.0 1358.0 114.0 -0.307 0.171 1000.0 -1000.0 -0.028 -1000.0 Retinoic acid receptors-mediated signaling 11.0 638.0 58.0 -0.118 0.035 1000.0 -1000.0 -0.035 -1000.0 FOXM1 transcription factor network 11.0 570.0 51.0 -0.215 0.032 1000.0 -1000.0 -0.097 -1000.0 Regulation of nuclear SMAD2/3 signaling 10.0 1468.0 136.0 -0.184 0.111 1000.0 -1000.0 -0.025 -1000.0 PLK2 and PLK4 events 10.0 30.0 3.0 -0.009 0.013 1000.0 -1000.0 0.001 -1000.0 Presenilin action in Notch and Wnt signaling 10.0 668.0 61.0 -0.129 0.051 1000.0 -1000.0 -0.017 -1000.0 Ceramide signaling pathway 10.0 823.0 76.0 -0.098 0.047 1000.0 -1000.0 -0.013 -1000.0 Calcium signaling in the CD4+ TCR pathway 10.0 335.0 31.0 -0.084 0.017 1000.0 -1000.0 -0.039 -1000.0 VEGFR1 specific signals 10.0 583.0 56.0 -0.066 0.017 1000.0 -1000.0 -0.012 -1000.0 Hedgehog signaling events mediated by Gli proteins 9.0 625.0 65.0 -0.075 0.041 1000.0 -1000.0 -0.029 -1000.0 Signaling events mediated by HDAC Class III 9.0 393.0 40.0 -0.131 0.038 1000.0 -1000.0 -0.005 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 9.0 504.0 52.0 -0.126 0.021 1000.0 -1000.0 -0.025 -1000.0 Paxillin-dependent events mediated by a4b1 9.0 350.0 36.0 -0.16 0.045 1000.0 -1000.0 -0.014 -1000.0 S1P4 pathway 9.0 229.0 25.0 -0.069 0.032 1000.0 -1000.0 -0.005 -1000.0 Sphingosine 1-phosphate (S1P) pathway 8.0 249.0 28.0 -0.092 0.04 1000.0 -1000.0 -0.008 -1000.0 Visual signal transduction: Cones 8.0 325.0 38.0 -0.04 0.019 1000.0 -1000.0 -0.002 -1000.0 Signaling mediated by p38-gamma and p38-delta 8.0 122.0 15.0 -0.012 0.019 1000.0 -1000.0 -0.003 -1000.0 Signaling events mediated by HDAC Class II 7.0 568.0 75.0 -0.075 0.038 1000.0 -1000.0 -0.019 -1000.0 Arf6 downstream pathway 7.0 315.0 43.0 -0.039 0.028 1000.0 -1000.0 -0.01 -1000.0 FAS signaling pathway (CD95) 7.0 339.0 47.0 -0.073 0.035 1000.0 -1000.0 -0.01 -1000.0 Regulation of p38-alpha and p38-beta 7.0 378.0 54.0 -0.077 0.044 1000.0 -1000.0 -0.028 -1000.0 IL6-mediated signaling events 7.0 540.0 75.0 -0.191 0.067 1000.0 -1000.0 -0.015 -1000.0 Class I PI3K signaling events 7.0 533.0 73.0 -0.096 0.025 1000.0 -1000.0 -0.014 -1000.0 Visual signal transduction: Rods 7.0 408.0 52.0 -0.076 0.021 1000.0 -1000.0 -0.032 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 6.0 372.0 54.0 -0.112 0.041 1000.0 -1000.0 -0.043 -1000.0 Regulation of Telomerase 6.0 622.0 102.0 -0.132 0.05 1000.0 -1000.0 -0.046 -1000.0 BCR signaling pathway 6.0 613.0 99.0 -0.075 0.049 1000.0 -1000.0 -0.04 -1000.0 Ras signaling in the CD4+ TCR pathway 6.0 118.0 17.0 -0.035 0.033 1000.0 -1000.0 -0.01 -1000.0 ErbB4 signaling events 5.0 374.0 69.0 -0.144 0.04 1000.0 -1000.0 -0.038 -1000.0 Insulin-mediated glucose transport 5.0 166.0 32.0 -0.049 0.035 1000.0 -1000.0 -0.015 -1000.0 TRAIL signaling pathway 5.0 267.0 48.0 -0.036 0.041 1000.0 -1000.0 -0.019 -1000.0 IL2 signaling events mediated by STAT5 5.0 125.0 22.0 -0.052 0.046 1000.0 -1000.0 -0.012 -1000.0 Class IB PI3K non-lipid kinase events 5.0 15.0 3.0 -0.006 0.006 1000.0 -1000.0 -0.001 -1000.0 Canonical NF-kappaB pathway 4.0 180.0 39.0 -0.058 0.047 1000.0 -1000.0 -0.026 -1000.0 Ephrin A reverse signaling 4.0 29.0 7.0 -0.002 0.008 1000.0 -1000.0 -0.001 -1000.0 JNK signaling in the CD4+ TCR pathway 4.0 74.0 17.0 -0.026 0.031 1000.0 -1000.0 -0.008 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 4.0 394.0 83.0 -0.047 0.041 1000.0 -1000.0 -0.012 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 4.0 209.0 45.0 -0.05 0.053 1000.0 -1000.0 -0.037 -1000.0 TCGA08_rtk_signaling 4.0 104.0 26.0 -0.051 0.036 1000.0 -1000.0 -0.005 -1000.0 Arf6 trafficking events 4.0 298.0 71.0 -0.066 0.044 1000.0 -1000.0 -0.02 -1000.0 Insulin Pathway 4.0 352.0 74.0 -0.075 0.041 1000.0 -1000.0 -0.035 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 4.0 132.0 33.0 -0.086 0.05 1000.0 -1000.0 -0.005 -1000.0 Regulation of Androgen receptor activity 4.0 284.0 70.0 -0.098 0.03 1000.0 -1000.0 -0.024 -1000.0 Aurora B signaling 4.0 317.0 67.0 -0.083 0.039 1000.0 -1000.0 -0.021 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 3.0 70.0 23.0 -0.036 0.04 1000.0 -1000.0 -0.014 -1000.0 FOXA2 and FOXA3 transcription factor networks 3.0 146.0 46.0 -0.128 0.024 1000.0 -1000.0 -0.039 -1000.0 EPO signaling pathway 3.0 208.0 55.0 -0.006 0.069 1000.0 -1000.0 -0.034 -1000.0 IFN-gamma pathway 3.0 238.0 68.0 -0.032 0.058 1000.0 -1000.0 -0.04 -1000.0 Signaling events mediated by HDAC Class I 3.0 392.0 104.0 -0.075 0.056 1000.0 -1000.0 -0.019 -1000.0 Atypical NF-kappaB pathway 3.0 120.0 31.0 -0.026 0.033 1000.0 -1000.0 -0.004 -1000.0 IL2 signaling events mediated by PI3K 3.0 181.0 58.0 -0.056 0.07 1000.0 -1000.0 -0.021 -1000.0 IL27-mediated signaling events 3.0 191.0 51.0 -0.062 0.035 1000.0 -1000.0 -0.036 -1000.0 Rapid glucocorticoid signaling 3.0 67.0 20.0 -0.015 0.017 1000.0 -1000.0 -0.004 -1000.0 Arf1 pathway 3.0 184.0 54.0 -0.018 0.031 1000.0 -1000.0 -0.008 -1000.0 ErbB2/ErbB3 signaling events 2.0 160.0 65.0 -0.069 0.042 1000.0 -1000.0 -0.027 -1000.0 Circadian rhythm pathway 2.0 44.0 22.0 -0.013 0.043 1000.0 -1000.0 -0.016 -1000.0 a4b1 and a4b7 Integrin signaling 2.0 12.0 5.0 0.005 0.026 1000.0 -1000.0 -0.001 -1000.0 Aurora C signaling 2.0 14.0 7.0 -0.0 0.025 1000.0 -1000.0 -0.007 -1000.0 PLK1 signaling events 2.0 186.0 85.0 -0.019 0.039 1000.0 -1000.0 -0.016 -1000.0 ceramide signaling pathway 2.0 98.0 49.0 -0.05 0.035 1000.0 -1000.0 -0.014 -1000.0 FoxO family signaling 2.0 177.0 64.0 -0.1 0.101 1000.0 -1000.0 -0.014 -1000.0 BARD1 signaling events 1.0 58.0 57.0 -0.037 0.063 1000.0 -1000.0 -0.015 -1000.0 Aurora A signaling 1.0 69.0 60.0 -0.003 0.048 1000.0 -1000.0 -0.003 -1000.0 mTOR signaling pathway 1.0 88.0 53.0 -0.01 0.035 1000.0 -1000.0 -0.027 -1000.0 Class I PI3K signaling events mediated by Akt 1.0 132.0 68.0 -0.037 0.046 1000.0 -1000.0 -0.013 -1000.0 p38 MAPK signaling pathway 1.0 82.0 44.0 -0.006 0.04 1000.0 -1000.0 -0.028 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 0.0 27.0 0.0 0.044 1000.0 -1000.0 -0.024 -1000.0 Alternative NF-kappaB pathway 0.0 10.0 13.0 -0.0 0.048 1000.0 -1000.0 -0.004 -1000.0 Total 1632 99830 7203 -13.6000675015 5.45590542269 131000 -131000 -2.87981621096 -131000